AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Air Products & Chemicals, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Matthew Lepore, EVP & General Counsel of Air Products & Chemicals, Inc. (APD), reported an acquisition of 3,471 shares of the company's common stock on 08/18/2025. The Form 4 shows the transaction coded as an acquisition with a price listed as $0.0000, and states 3,471 shares are beneficially owned following the reported transaction, held directly. The filing is signed by Andrea I. Rennig as attorney-in-fact on 08/20/2025. No derivative securities or additional transactions are reported and the form does not include further context such as the reason for the $0.0000 price (e.g., grant, gift, or correction) or any change in reporting status.

Matthew Lepore, EVP e General Counsel di Air Products & Chemicals, Inc. (APD), ha comunicato l'acquisto di 3.471 azioni del capitale sociale della società in data 18/08/2025. Il modulo Form 4 riporta la transazione come acquisizione con un prezzo indicato di $0.0000 e specifica che, a seguito dell'operazione, sono possedute beneficiariamente 3.471 azioni detenute direttamente. La dichiarazione è firmata da Andrea I. Rennig in qualità di procuratore il 20/08/2025. Non risultano riportati strumenti derivati o operazioni aggiuntive e il modulo non fornisce ulteriori dettagli sul motivo del prezzo di $0.0000 (ad es. assegnazione, dono o correzione) né su eventuali cambiamenti nello status di segnalazione.

Matthew Lepore, EVP y Consejero General de Air Products & Chemicals, Inc. (APD), notificó la adquisición de 3.471 acciones de las acciones ordinarias de la compañía el 18/08/2025. El Formulario 4 muestra la operación codificada como adquisición con un precio indicado de $0.0000, y declara que tras la transacción se poseen beneficiariamente 3.471 acciones mantenidas directamente. La presentación está firmada por Andrea I. Rennig como apoderada el 20/08/2025. No se informan valores derivados ni transacciones adicionales y el formulario no incluye contexto adicional sobre la razón del precio de $0.0000 (por ejemplo, concesión, regalo o corrección) ni sobre ningún cambio en el estado de notificación.

Matthew Lepore, Air Products & Chemicals, Inc.(APD)ì� EVP ê²� 법무ì´ê´„ì€ 2025-08-18ì—� 회사 보통ì£� 3,471ì£�ë¥� ì·¨ë“í•� 것으ë¡� 보고했습니다. Form 4ì—는 거래가 ì·¨ë“으로 기재ë˜ì–´ 있고 ê°€ê²©ì€ $0.0000ë¡� 표기ë˜ì–´ 있으ë©�, ë³´ê³ ë� 거래 í›� 3,471ì£�ë¥� ì§ìΪ 실질 보유하고 있다ê³� 명시ë˜ì–´ 있습니다. 제출서는 2025-08-20ì—� ëŒ€ë¦¬ì¸ ìžê²©ìœ¼ë¡œ Andrea I. Rennigì� 서명했습니다. 파ìƒì¦ê¶Œì´ë‚˜ 추가 거래ëŠ� ë³´ê³ ë˜ì§€ 않았ê³�, ì� $0.0000 ê°€ê²©ì´ ë¶€ì—�, ì¦ì—¬, ì •ì • ë“� ì–´ë–¤ 사유 때문ì¸ì§€ ë˜ëŠ” ë³´ê³  ì§€ìœ� ë³€ê²½ì— ëŒ€í•� 추가 ì„¤ëª…ì€ í¬í•¨ë˜ì–´ 있지 않습니다.

Matthew Lepore, EVP et General Counsel d'Air Products & Chemicals, Inc. (APD), a déclaré une acquisition de 3 471 actions des actions ordinaires de la société le 18/08/2025. Le formulaire Form 4 indique la transaction comme une acquisition avec un prix mentionné de 0,0000 $, et précise qu'après la transaction déclarée, 3 471 actions sont détenues à titre bénéficiaire directement. Le dépôt est signé par Andrea I. Rennig en tant que mandataire le 20/08/2025. Aucun titre dérivé ni transaction supplémentaire n'est signalé et le formulaire n'apporte pas d'informations supplémentaires sur la raison du prix de 0,0000 $ (par ex. attribution, don ou correction) ni sur un éventuel changement de statut de déclaration.

Matthew Lepore, EVP und General Counsel von Air Products & Chemicals, Inc. (APD), meldete am 18.08.2025 den Erwerb von 3.471 Aktien des Stammkapitals des Unternehmens. Das Formblatt Form 4 führt die Transaktion als Erwerb mit einem angegebenen Preis von $0.0000 auf und weist aus, dass nach der gemeldeten Transaktion 3.471 Aktien direkt wirtschaftlich gehalten werden. Die Einreichung ist von Andrea I. Rennig als Bevollmächtigte am 20.08.2025 unterschrieben. Es werden keine derivativen Wertpapiere oder zusätzlichen Transaktionen gemeldet, und das Formular enthält keine weiteren Angaben zum Grund für den Preis von $0.0000 (z. B. Zuteilung, Schenkung oder Korrektur) oder zu Änderungen des Meldezustands.

Positive
  • Insider acquisition disclosed, increasing transparency about officer holdings
  • Form filed timely and signed by attorney-in-fact, indicating compliance with reporting requirements
Negative
  • Price listed as $0.0000 with no explanation in the filing, leaving the nature of the acquisition unclear

Insights

TL;DR: Officer acquisition disclosed; price field shows $0.0000 which requires context but filing correctly reports beneficial ownership.

The Form 4 documents a straightforward non-derivative acquisition by a named officer, showing 3,471 shares held directly after the transaction. The listed price of $0.0000 is explicitly shown in the filing and likely indicates a non-cash grant or a reporting convention, but the document contains no further explanation. For compliance purposes, the filing appears to follow Section 16 reporting mechanics and includes an attorney-in-fact signature. Investors and compliance teams would typically seek the underlying grant agreement or company disclosure to understand the zero price.

TL;DR: Small officer share acquisition disclosed; immaterial to APD’s capitalization but useful for transparency.

The transaction size (3,471 shares) is modest relative to a large-cap issuer and the report indicates direct ownership post-transaction. No derivatives, dispositions, or larger ownership changes are shown. The filing enhances transparency around insider holdings but, on its face, is unlikely to materially affect investor valuation or control metrics. Additional company-level disclosures would be needed to assess compensation implications.

Matthew Lepore, EVP e General Counsel di Air Products & Chemicals, Inc. (APD), ha comunicato l'acquisto di 3.471 azioni del capitale sociale della società in data 18/08/2025. Il modulo Form 4 riporta la transazione come acquisizione con un prezzo indicato di $0.0000 e specifica che, a seguito dell'operazione, sono possedute beneficiariamente 3.471 azioni detenute direttamente. La dichiarazione è firmata da Andrea I. Rennig in qualità di procuratore il 20/08/2025. Non risultano riportati strumenti derivati o operazioni aggiuntive e il modulo non fornisce ulteriori dettagli sul motivo del prezzo di $0.0000 (ad es. assegnazione, dono o correzione) né su eventuali cambiamenti nello status di segnalazione.

Matthew Lepore, EVP y Consejero General de Air Products & Chemicals, Inc. (APD), notificó la adquisición de 3.471 acciones de las acciones ordinarias de la compañía el 18/08/2025. El Formulario 4 muestra la operación codificada como adquisición con un precio indicado de $0.0000, y declara que tras la transacción se poseen beneficiariamente 3.471 acciones mantenidas directamente. La presentación está firmada por Andrea I. Rennig como apoderada el 20/08/2025. No se informan valores derivados ni transacciones adicionales y el formulario no incluye contexto adicional sobre la razón del precio de $0.0000 (por ejemplo, concesión, regalo o corrección) ni sobre ningún cambio en el estado de notificación.

Matthew Lepore, Air Products & Chemicals, Inc.(APD)ì� EVP ê²� 법무ì´ê´„ì€ 2025-08-18ì—� 회사 보통ì£� 3,471ì£�ë¥� ì·¨ë“í•� 것으ë¡� 보고했습니다. Form 4ì—는 거래가 ì·¨ë“으로 기재ë˜ì–´ 있고 ê°€ê²©ì€ $0.0000ë¡� 표기ë˜ì–´ 있으ë©�, ë³´ê³ ë� 거래 í›� 3,471ì£�ë¥� ì§ìΪ 실질 보유하고 있다ê³� 명시ë˜ì–´ 있습니다. 제출서는 2025-08-20ì—� ëŒ€ë¦¬ì¸ ìžê²©ìœ¼ë¡œ Andrea I. Rennigì� 서명했습니다. 파ìƒì¦ê¶Œì´ë‚˜ 추가 거래ëŠ� ë³´ê³ ë˜ì§€ 않았ê³�, ì� $0.0000 ê°€ê²©ì´ ë¶€ì—�, ì¦ì—¬, ì •ì • ë“� ì–´ë–¤ 사유 때문ì¸ì§€ ë˜ëŠ” ë³´ê³  ì§€ìœ� ë³€ê²½ì— ëŒ€í•� 추가 ì„¤ëª…ì€ í¬í•¨ë˜ì–´ 있지 않습니다.

Matthew Lepore, EVP et General Counsel d'Air Products & Chemicals, Inc. (APD), a déclaré une acquisition de 3 471 actions des actions ordinaires de la société le 18/08/2025. Le formulaire Form 4 indique la transaction comme une acquisition avec un prix mentionné de 0,0000 $, et précise qu'après la transaction déclarée, 3 471 actions sont détenues à titre bénéficiaire directement. Le dépôt est signé par Andrea I. Rennig en tant que mandataire le 20/08/2025. Aucun titre dérivé ni transaction supplémentaire n'est signalé et le formulaire n'apporte pas d'informations supplémentaires sur la raison du prix de 0,0000 $ (par ex. attribution, don ou correction) ni sur un éventuel changement de statut de déclaration.

Matthew Lepore, EVP und General Counsel von Air Products & Chemicals, Inc. (APD), meldete am 18.08.2025 den Erwerb von 3.471 Aktien des Stammkapitals des Unternehmens. Das Formblatt Form 4 führt die Transaktion als Erwerb mit einem angegebenen Preis von $0.0000 auf und weist aus, dass nach der gemeldeten Transaktion 3.471 Aktien direkt wirtschaftlich gehalten werden. Die Einreichung ist von Andrea I. Rennig als Bevollmächtigte am 20.08.2025 unterschrieben. Es werden keine derivativen Wertpapiere oder zusätzlichen Transaktionen gemeldet, und das Formular enthält keine weiteren Angaben zum Grund für den Preis von $0.0000 (z. B. Zuteilung, Schenkung oder Korrektur) oder zu Änderungen des Meldezustands.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LEPORE MATTHEW

(Last) (First) (Middle)
1940 AIR PRODUCTS BLVD.

(Street)
ALLENTOWN PA 18106-5500

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Air Products & Chemicals, Inc. [ APD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 A 3,471 A $0.0000(1) 3,471 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Not applicable to this security
Andrea I. Rennig as Attorney in Fact 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did APD insider Matthew Lepore report on Form 4?

The Form 4 reports that Matthew Lepore acquired 3,471 shares of APD common stock on 08/18/2025 and beneficially owns 3,471 shares following the transaction.

What is the reported purchase price for the shares on the Form 4?

The filing shows a price of $0.0000 for the reported acquisition; the form does not explain the reason for that price.

Is the acquisition direct or indirect according to the filing?

The Form 4 indicates the ownership form is Direct (D), meaning the reporting person holds the shares directly.

Were any derivative securities reported in this filing for APD?

No. Table II for derivative securities shows no reported transactions or holdings in this filing.

Who signed the Form 4 and when was it signed?

The Form 4 is signed by Andrea I. Rennig as Attorney in Fact on 08/20/2025.
Air Prods & Chems Inc

NYSE:APD

APD Rankings

APD Latest News

APD Latest SEC Filings

APD Stock Data

64.13B
221.67M
0.4%
94.72%
2.28%
Specialty Chemicals
Industrial Inorganic Chemicals
United States
ALLENTOWN